) enhances immunity to Listeria monocytogenes (LM) and Salmonella enterica serovar Typhimurium (ST) in the nonpregnant state by inhibiting pathogen-induced immune cell death. However, the roles of IFNAR signaling in modulating immunity to infection during pregnancy are not well understood.
| INTRODUC TI ON
Type I interferons (IFNs) are a large family of cytokines that modulate innate and adaptive immune responses, including inflammatory cytokine expression, macrophage activation, and T-cell function. 1 The IFN-α and IFN-β subtypes are well characterized for their roles in regulating host immunity to infections and will be referred to as Type I IFNs in this study. 2 Type I IFNs signal through the ubiquitous transmembrane IFN-alpha receptor (IFNAR). 3 They are produced by innate immune cell types, including macrophages and dendritic cells (DCs) upon pathogen detection by pattern recognition receptors and cytokine stimulation. 3, 4 Non-immune cells,
including epithelial cells and fibroblasts, also promote activation of antimicrobial mechanisms through IFN-β production. 3 Type I IFNs induce differential effects on host immunity to viral infections.
IFNAR signaling typically exerts antiviral functions through induction of IFN-stimulated genes (ISGs), which encode proteins that interfere with various stages of the viral life cycle, regulate host cell death and promote activation of innate and adaptive immune mechanisms. 5, 6 However, IFNAR signaling enhances susceptibility to chronic infection by lymphocytic choriomeningitis virus (LCMV) infection. This is associated with increased serum expression of anti-inflammatory interleukin-10 (IL-10) and programmed deathligand 1, and decreased splenic numbers of cytokine-producing LCMV-specific CD4 + T cells. 7, 8 IFNAR signaling also induces differential host responses to bacterial infections. Type I IFNs enhance resistance to macrophage infection by Legionella pneumophila bacteria by promoting polarization of classically activated M1 macrophage responses and production of antimicrobial nitric oxide.
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Protection mediated by type I IFNs from invasive lung infection by
Streptococcus pneumoniae bacteria is associated with reduced lung epithelial permeability and enhanced alveolar epithelial type II cell survival. 10, 11 In contrast, IFNAR signaling compromises innate immunity to intracellular bacterial infection by Listeria monocytogenes (LM) and Salmonella Typhimurium (ST) by sensitizing immune cells to pathogen-induced death. [12] [13] [14] Thus, the complex network of immune activation and regulatory roles mediated by type I IFNs differentially impacts host immunity to infection.
Pregnancy features the complex interplay between inflammatory and immune-regulatory T-cell mechanisms to promote maternal tolerance to the semi-allogeneic fetus. As a consequence, this immune-altered condition can also modulate host susceptibility to infections. We previously showed that pregnancy does not compromise the inherent resistance of C57BL/6J wild-type (WT) mice to systemic LM infection. 15 This is associated with robust systemic innate immune and antigen-specific CD8 + T-cell responses by pregnant mice similar to those of non-pregnant mice.
However, pregnant mice exhibited progressive bacterial growth in the placenta and enhanced fetal loss in the course of LM infection. Thus, preferential placental colonization by LM appeared to be differentially regulated by maternal systemic and local placental immunity in response to infection. In contrast, ST infection during pregnancy leads to profound systemic maternal and fetal disease. [16] [17] [18] Pregnant mice exhibited reduced maternal splenic innate immune responses to infection, which was associated with decreased ratio of pro-inflammatory Th17 cells to anti-inflammatory regulatory T cells (Tregs) and enhanced IL-10 responses.
16,18
In contrast, profound placental infection correlated with enhanced expression of pro-inflammatory cytokines, including interleukin-6 (IL-6), TNF, and IL-18, leading to fetal loss. 17, 18 Thus, compartmentspecific dichotomy between pro-and anti-inflammatory responses in pregnant mice impacted systemic and placental ST burden and disease progression. 
| MATERIAL S AND ME THODS
| Mice and matings
C57BL/6J wild-type (WT) mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA). IFNAR −/− mice bred on the WT background were obtained from Dr Kaja Murali-Krishna (Emory University, Atlanta, GA, USA). Matings were performed by housing one male with one to two females for two nights. The presence of a copulatory plug after each day of mating was designated as day 0 of pregnancy. The rates of fetal resorptions, which are defined as uterine necrotic scars or as necrotic and/or hemorrhagic fetuses and placentas, were calculated using the formula R/(R + V) × 100, where R is the number of resorbing fetuses and V is the number of viable fetuses per mouse. The study was performed in accordance with the guidelines of the Canadian Council on Animal Care and the protocols approved by National Research Council Canada in Ottawa, Canada.
| Infections and bacterial enumeration
Listeria monocytogenes 10403S (LM) and Salmonella enterica serovar Typhimurium SL1344 (ST) were grown to midlog phase at OD 600 = 1.0
and OD 600 = 0.8, respectively, under constant shaking in Bacto™ brainheart infusion (BHI) medium (BD, Mississauga, ON, Canada) containing 50 µg/mL streptomycin (Sigma-Aldrich, Oakville, ON, Canada).
Bacterial stocks were stored frozen in 20% glycerol at −80°C. 
| Flow cytometric analysis
Spleens and individual placentas (with intact deciduas) were homogenized and passed through a 100-µm cell strainer to obtain a single-cell suspension. 
| Cytokine measurements
Serum was obtained from blood using Microtainer ® serum separa- 
| Statistical analysis
All statistical analyses were performed using GraphPad ® Prism 7
(GraphPad, La Jolla, CA, USA) software. Bacterial CFUs, immune cell numbers and percentages, and cytokine expression levels were presented as mean ± SEM. Statistical significance of CFU, flow cytometry, and cytokine expression data was determined through Mann-Whitney U test. Survival curves were analyzed using the Gehan-BreslowWilcoxon test. P values of ≤0.05 were considered statistically significant. *P ≤ 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
| RE SULTS AND D ISCUSS I ON
| Type I IFNs modulate splenic and placental immune cell distributions and serum cytokine expression
We first determined the total splenic numbers in non-pregnant and pregnant WT and IFNAR mice by counting live cells using the Cellometer. In the non-infected state, pregnant WT and IFNAR −/− mice exhibited elevated total splenic cell numbers at day 14-15 of pregnancy relative to their non-pregnant counterparts ( Figure 1A ). We then analyzed the distribution of immune cell subsets in the spleen and individual placentas through flow cytometry.
The increased total splenic numbers in WT and IFNAR −/− mice during pregnancy correlated with a general increase in splenic myeloid (macrophages and neutrophils) and lymphoid (B cells, T cells, and NK cells) immune cell subsets during normal gestation ( Figure 1B and Figure S1A ). 21 It is proposed that the elevation of circulating granulocyte and monocyte numbers in the maternal host acts as a compensatory mechanism for pregnancy-related changes in Th17 cells and Tregs. 22 Furthermore, the spleen contains a reserve of monocytes that are rapidly recruited to inflammatory sites during infection. 23 We observed a decrease in splenic monocyte numbers in non-pregnant IFNAR −/− mice compared to their WT counterparts, consistent with a previous study ( Figure 1B ). 24 We also show group. Data are presented as mean ± SEM. Statistical significance was analyzed by Mann-Whitney U test. *P ≤ 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NPNI, non-pregnant non-infected; PNI, pregnant non-infected cells, and increased levels of macrophages and DCs in the placenta relative to WT mice ( Figure 1C, Figure S1B ). No significant differences were observed in placental neutrophil and T-cell (CD4 + and CD8 + ) percentages between the two mouse strains. We then examined cytokine expression in the maternal systemic and placental compartments. Baseline levels of MCP-1 and KC were observed in the serum ( Figure 1D and Figure S1C ). MCP-1 (CCL2) is a chemoattractant of monocytes, macrophages, NK cells, and memory T cells. 25 Furthermore, KC promotes neutrophil recruitment and regulates neutrophil and T-cell functionality during infection. by Mann-Whitney U test. *P ≤ 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NPI, non-pregnant infected; PNI, pregnant non-infected; PI, pregnant infected.
| IFNAR deficiency confers host protection from LM infection during pregnancy
The genetic resistance of C57BL/6J (WT) mice against LM is primarily attributed to the resistant allele at the Hc locus on chromosome 2. 27 We previously showed that this protection from infection is not adversely impacted within the systemic compart- where no significant differences were observed between the two groups ( Figure 2G ). Splenic IL-12p70 expression was similarly low in all non-pregnant and pregnant groups ( Figure S2E ). Furthermore, non-pregnant and pregnant IFNAR −/− mice showed reduced splenic IL-10 expression levels compared to their WT counterparts. In the placenta, KC, MCP-1 TNF, IL-6, IFN-γ, and IL-12p70 expression Bacterial burden, resorption rates, cell numbers and percentages, and cytokine expression levels are presented as mean ± SEM. Statistical significance was analyzed by MannWhitney U test. *P ≤ 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NPI, non-pregnant infected; PNI, pregnant non-infected; PI, pregnant infected were similar between the two mouse strains at day 3 post-infection ( Figure S2F ). This indicates that increased control of placental infection in IFNAR −/− mice is not due to an altered placental inflammatory profile, but may be attributed to efficient initial control of infection in the systemic compartment. Thus, our results indicatecompartment-specificregulation of cytokine responses in non-pregnant and pregnant hosts during systemic LM infection.
Furthermore, enhanced serum IL-12 expression associated with IFNAR deficiency may be a critical indicator of host resistance to LM infection during pregnancy.
| Pregnancy compromises host protection conferred by IFNAR deficiency against ST infection
Pregnancy enhances maternal and fetal disease progression in mice during ST infection. In the non-pregnant state, ST-resistant 129x1/ SvJ mice infected with ST 1 x10 3 CFUs iv exhibit chronic disease for ~60 days prior to bacterial clearance. 18 In contrast, pregnant 129x1/ SvJ mice infected during midpregnancy (day 10-12 of gestation)
show significantly decreased survival rates (~40%) relative to non- pro-inflammatory cytokine expression in systemic and uterine compartments, and enhance susceptibility to secondary bacterial infection-driven pre-term births. 40 This result supports the prevailing "double-hit" hypothesis, wherein viral infection enhances the risk of invasive bacterial infection in the maternal host and adverse pregnancy outcomes. [40] [41] [42] Furthermore, viral-induced inhibition of IFN-β expression enhances pro-inflammatory cytokine production and placental trophoblast cell sensitivity to LPS. 43 We have previously
shown that TLR4 expression is associated with robust pro-inflammatory cytokine production in pregnant mice in response to ST infection, leading to increased maternal disease progression and fetal deaths. 16 Taken together, these results highlight the complex signaling networks regulated by IFNAR and TLR-mediated inflammation in host immunity to infection duringpregnancy.Achieving a balance between pro-inflammatory and anti-inflammatory responses in maternal systemic and fetal-placental compartments is critical in determining pregnancy outcomes.
| CON CLUS ION
Our study highlights the critical roles of IFNAR signaling in modulating immune cell distribution and cytokine expression, leading to differential responses to intracellular infections during preg- 
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